Status:
UNKNOWN
Protein S100 Beta as a Predictor of Resuscitation Outcome
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Cardiopulmonary Arrest Outcome
Eligibility:
All Genders
18+ years
Brief Summary
Management of cardiac arrest is complicated by the lack of a readily available tool identifying individuals who are likely to be successfully resuscitated. S100 beta is a protein that originates in th...
Eligibility Criteria
Inclusion
- All victims of non-traumatic out-of hospital cardiopulmonary arrest (defined as the absence of either spontaneous respiration or palpable pulse or both) within the Jerusalem district.
Exclusion
- Patients with do-not-resuscitate orders or an advance directive to that effect.
- Patients with intracranial hemorrhage
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
313 Patients enrolled
Trial Details
Trial ID
NCT00814814
Start Date
February 1 2008
End Date
November 1 2021
Last Update
November 16 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaare Zedek Medical Center
Jerusalem, Israel, 91031
2
Hadassah Medical Center
Jerusalem, Israel, 91120